Prevention of migraine by supraorbital transcutaneous neurostimulation using the Cefaly® device (PREMICE): a multi-centre, randomized, sham-controlled trial

por Schoenen, J, Vandersmissen, B, Jeangette, S, Herroelen, L, Vandenheede, M, Gerard, P, Magis, D
Publicado 2013